Yue-ning Sun

Novel CDK9 inhibitor oroxylin A promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signaling

Shu Xu, Ye Xu, Libin Wei, 2021, Acta Pharmacologica Sinica.

Novel CDK9 inhibitor oroxylin A promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signaling

Q. Guo, Shu Xu, Jingyue Yao, 2021, Acta Pharmacologica Sinica.

Dual PPARγ/ɑ Agonist Oroxyloside Suppresses Cell Cycle Progression by Glycolipid Metabolism Switch-Mediated Increase of Reactive Oxygen Species Levels.

Wei Li, Zhiyu Li, Libin Wei, 2021, Free radical biology & medicine.

CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma

Q. Guo, Jian Liu, Ye Xu, 2021, Autophagy.

Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma

Jinbao Liu, Jinghong Chen, Xianping Shi, 2019, Journal of Experimental & Clinical Cancer Research.

Pseudolaric acid B induces mitotic arrest and apoptosis in both imatinib-sensitive and -resistant chronic myeloid leukaemia cells.

Jinbao Liu, Yuening Sun, Xianping Shi, 2020, European journal of pharmacology.

TRIM26 promotes non-small cell lung cancer survival by inducing PBX1 degradation

X. Mao, Ying Ren, Peng Lin, 2023, International journal of biological sciences.

AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant CTNNB1 mutations.

Q. Guo, Ye Xu, Libin Wei, 2023, Cancer letters.

Apoptosis induction in human prostate cancer cells related to the fatty acid metabolism by wogonin-mediated regulation of the AKT-SREBP1-FASN signaling network.

Dechao Wang, Yuening Sun, Qinglong Guo, 2022, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Inhibition of mitochondrial fusion via SIRT1/PDK2/PARL axis breaks mitochondrial metabolic plasticity and sensitizes cancer cells to glucose restriction therapy.

Libin Wei, Ruitian Zhang, Wenjing Guo, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.